Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats

Experimental Physiology

Volumn 92, Issue 6, 2007, Pages 1047-1056

  Rouyer, Olivier ^a   Zoll, Joffrey ^a   Daussin, Frederic ^a   Damgé, Christiane ^a   Helms, Pauline ^a   Talha, Sami ^a   Rasseneur, Laurence ^a   Piquard, Francois ^a   Geny, Bernard ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Service de Physiologie et d' Explorations Fonctionnelles   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; EXERCISE; GASTROCNEMIUS MUSCLE; HEMODYNAMICS; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUSCLE FUNCTION; NONHUMAN; OXIDATION; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

EID: 35248869623     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.038851     Document Type: Article

References (53)

1. American Diabetes Association (1999). Diabetes mellitus and exercise (Position Statement). Diabetes Care 22, S49 S53.
2. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX & Ventura-Clapier R (2004). Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96, 59 64.
3. Blomstrand E, Radegran G & Saltin B (1997). Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle. J Physiol 501, 455 460.
4. Challiss RA, Vranic M & Radda GK (1989). Bioenergetic changes during contraction and recovery in diabetic rat skeletal muscle. Am J Physiol Endocrinol Metab 256, E129 E137.
5. Crowther GJ, Milstein JM, Jubrias SA, Kushmerick MJ, Gronka RK & Conley KE (2003). Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes. Am J Physiol Endocrinol Metab 284, E655 E662.
6. Dal Ponte DB, Fogt DL, Jacob S & Henriksen EJ (1998). Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance. Metabolism 47, 982 987.
7. de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L & Fraga CG (2003). Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17, 1096 1098.
8. de Cavanagh EM, Piotrkowski B & Fraga CG (2004). Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging. Mol Aspects Med 25, 27 36.
9. El Midaoui A, Tancrede G & Nadeau A (1996). Effect of physical training on mitochondrial function in skeletal muscle of normal and diabetic rats. Metabolism 45, 810 816.
10. Ferrari R, Pasanisi G, Notarstefano P, Campo G, Gardini E & Ceconi C (2005). Specific properties and effect of perindopril in controlling the renin-angiotensin system. Am J Hypertens 18, 142S 154S.
11. Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R & Masson S (2006). Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci 79, 121 129.
12. Foianini KR, Steen MS, Kinnick TR, Schmit MB, Youngblood EB & Henriksen EJ (2000). Effects of exercise training and ACE inhibition on insulin action in rat skeletal muscle. J Appl Physiol 89, 687 694.
13. Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, Bassal S, El-Osta A, Long DM, Panagiotopoulos S, Jerums G, Osicka TM & Cooper ME (2005). Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol 16, 2363 2372.
14. Frisbee JC, Weber DS & Lombard JH (1999). Chronic captopril administration decreases vasodilator responses in skeletal muscle arterioles. Am J Hypertens 12, 705 715.
15. Giudicelli JF, Richer C, Richard C & Thuillez C (1991). Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. Am J Hypertens 4, 258S 262S.
16. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G & Margreiter R (1998). Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 201, 1129 1139.
17. Goyal RK, Satia MC, Bangaru RA & Gandhi TP (1998). Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats. J Cardiovasc Pharmacol 32, 317 322.
18. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF & Narayan KM (2003). Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 163, 1440 1447.
19. Hartmann JF, Szemplinski M, Hayes NS, Keegan ME & Slater EE (1988). Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens 6, 677 683.
20. HOPE Study Investigators (2000). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355, 253 259.
21. Howarth FC, Jacobson M, Shafiullah M & Adeghate E (2005). Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90, 827 835.
22. Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD & McMurdo M (2002). Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 88, 373 377.
23. Jacob S, Henriksen EJ, Fogt DL & Dietze1 GJ (1996). Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45, 535 541.
24. Jones A, Montgomery HE & Woods DR (2002). Human performance: a role for the ACE genotype? Exerc Sport Sci Rev 184, 184 190.
25. Karlsson HK, Ahlsen M, Zierath JR, Wallberg-Henriksson H & Koistinen HA (2006). Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes 55, 1283 1288.
26. Kivela R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H & Vihko V (2006). Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J 20, 1570 1572.
27. Komatsu WR, Gabbay MA, Castro ML, Saraiva GL, Chacra AR, De Barros Neto TL & Dib SA (2005). Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus. Pediatr Diabetes 6, 145 149.
28. Lagouge MM, Argman C, Gergart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P & Auwerx J (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 217, 1 14.
29. Letellier T, Heinrich R, Malgat M & Mazat JP (1994). The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J 302, 171 174.
30. Mason NJ (2006). Exercise frequency and arterial compliance in non-diabetic and type 1 diabetic individuals. Eur J Cardiovasc Prev Rehab 13, 598 603.
31. Minami N, Mori N, Nagasaka M, Harada T, Kurosawa H, Kanazawa M & Kohzuki M (2004). Effect of high-salt diet or chronic captopril treatment on exercise capacity in normotensive rats. Clin Exp Pharmacol Physiol 31, 197 201.
32. Momken I, Kahapip J, Bahi L, Badoual T, Hittinger L, Ventura-Clapier R & Veksler V (2003). Does angiotensin-converting enzyme inhibition improve the energetic status of cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol 35, 399 407.
33. Moreira PI, Rolo AP, Sena C, Seica R, Oliveira CR & Santos MS (2006). Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med Chem 2, 299 308.
34. Nisoli E, Clementi E, Carruba MO & Moncada S (2007). Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 30, 795 806.
35. Onozato ML, Tojo A, Goto A, Fujita T & Wilcox CS (2002). Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61, 186 194.
36. Peltoniemi P, Yki-Jarvinen H, Oikonen V, Oksanen A, Takala TO, Ronnemaa T, Erkinjuntti M, Knuuti MJ & Nuutila P (2001). Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin-resistant skeletal muscle of patients with type 1 diabetes. Diabetes 50, 1371 1377.
37. Poortmans JR, Saerens P, Edelman R, Vertongen FM & Dorchy H (1986). Influence of the degree of metabolic control on physical fitness in type I diabetic adolescents. Int J Sports Med 7, 232 235.
38. Predel HG, Rohden C, Heine O, Prinz U & Rost RE (1994). ACE inhibition and physical exercise: studies on physical work capacity, energy metabolism, and maximum oxygen uptake in well-trained, healthy subjects. J Cardiovasc Pharmacol 23, S25 S28.
39. Py G, Lambert K, Milhavet O, Eydoux N, Prefaut C & Mercier J (2002). Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters. Metabolism 51, 807 813.
40. Raile K, Kapellen T, Schweiger A, Hunkert F, Nietzschmann U, Dost A & Kiess W (1999). Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care 22, 904 1905.
41. Ramires PR, Forjaz CL, Strunz CM, Silva ME, Diament J, Nicolau W, Liberman B & Negrao CE (1997). Oral glucose ingestion increases endurance capacity in normal and diabetic (type I) humans. J Appl Physiol 83, 608 614.
42. Ritz P & Berrut G (2005). Mitochondrial function, energy expenditure, aging and insulin resistance. Diabetes Metab 31 (spec. no. 2 5S67 5S73.
43. Rolo AP & Palmeira CM (2006). Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 15, 167 178.
44. Saks VA, Veksler VI, Kuznetsov AV, Kay L, Sikk P, Tiivel T, Tranqui L, Olivares J, Winkler K, Wiedemann F & Kunz WS (1998). Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 184, 81 100.
45. Steen MS, Foianini KR, Youngblood EB, Kinnick TR, Jacob S & Henriksen EJ (1999). Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. J Appl Physiol 86, 2044 2051.
46. Stettler C, Jenni S, Allemann S, Steiner R, Hoppeler H, Trepp R, Christ ER, Zwahler M & Diem P (2006). Exercise capacity in subjects with type 1 diabetes mellitus in eu- and hyperglycemia. Diabetes Metab Res Rev 22, 300 306.
47. Thaveau F, Zoll J, Rouyer O, Chakfé N, Kretz JG, Piquard F, Geny B (2007). Ischemic preconditioning specifically restores complexes I and II activities of the mitochondrial respiratory chain in ischemic skeletal muscle. J Vasc Surg 46, 541 547.
48. Van Lunteren E, Moyer M & Pollarine J (2004). Reduced amount and disrupted temporal pattern of spontaneous exercise in diabetic rats. Med Sci Sports Exerc 36, 1856 1862.
49. Veves A, Saouaf R, Donaghue VM, Mullooly CA, Kistler JA, Giurini JM, Horton ES & Fielding RA (1997). Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes 46, 1846 1852.
50. Zoll J, Monassier L, Garnier A, N'Guessan B, Mettauer B, Veksler V, Piquard F, Ventura-Clapier R & Geny B (2006). ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101, 385 391.
51. Zoll J, N'Guessan B, Ribera F, Lampert E, Fortin D, Veksler V, Bigard X, Geny B, Lonsdorfer J, Ventura-Clapier R & Mettauer B (2003). Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 42, 126 132.
52. Zoll J, Ponsot E, Doutreleau S, Mettauer B, Piquard F, Mazzucotelli JP, Diemunsch P & Geny B (2005). Acute myocardial ischemia induces specific alterations of ventricular mitochondrial function in experimental pigs. Acta Physiol Scand 185, 25 32.
53. Zoll J, Sanchez H, N'Guessan B, Ribera F, Lampert E, Bigard X, Serrurier B, Fortin D, Geny B, Veksler B, Ventura-Clapier R & Mettauer B (2002). Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543, 191 200.